超越解剖:直肠癌管理应走向生物学导向、反应适应与以患者为中心
本文为通讯文章,针对Noiret等关于局部晚期直肠癌(LARC)解剖导向治疗的综述提出不同观点。作者认为过度以解剖为中心可能简化治疗选择并低估患者偏好与生物学决定因素,现有证据不支持化疗后手术在长期功能结局上优于全程新辅助治疗(TNT)联合器官保留(OP)。未来应优先生物学风险分层、反应适应治疗和多组学标志物整合。
要点
- 反对过度解剖中心框架,治疗选择应整合患者偏好与生物学反应决定因素。
- 现有证据不支持化疗后手术长期功能结局优于TNT联合OP。
- 未来范式应优先生物学风险分层、反应适应治疗与多组学标志物。
核心结论
- LARC治疗不应仅基于解剖,应转向生物学风险分层、反应适应和以患者为中心的综合决策。
研究设计与样本
- 本文为通讯文章,针对Noiret等关于LARC解剖导向治疗策略的综述进行扩展讨论。
主要发现
- 肿瘤位置影响手术复杂性和功能结局,但过度解剖中心框架可能简化治疗选择并低估患者偏好和生物学反应决定因素。
- 当前证据不支持化疗后手术相比TNT联合OP提供更优长期功能结局的断言。
- 现代放疗技术和OP策略相比根治性手术显示出有利的反应率、功能结局和生活质量。
临床怎么用
- LARC治疗决策应整合患者偏好、肿瘤学风险、功能结局和不断发展的生物学理解,以优化个体化治疗。
- 未来治疗范式应优先考虑生物学风险分层、反应适应治疗和多组学标志物的整合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of this correspondence is to expand upon the recent review article by Noiret et al. addressing management of locally advanced rectal cancer (LARC) and proposing anatomically guided treatment strategies. While tumor location influences surgical complexity and functional outcomes, we caution against an overly anatomy centric framework that may oversimplify treatment selection and underemphasize patient preferences and biological determinants of response. Current evidence does not support the assertion that chemotherapy followed by surgery provides superior long-term functional outcomes compared with total neoadjuvant therapy (TNT) with organ preservation (OP). Contemporary management of LARC includes multiple curative-intent strategies, each associated with distinct tradeoffs in oncologic control, toxicity, and quality of life. In particular, modern radiotherapy techniques and OP strategies have demonstrated favorable response rates, functional outcomes, and quality of life compared with radical surgery. We argue that future treatment paradigms should move beyond anatomy alone and prioritize biologic risk stratification, response adaptive treatment, and incorporation of multi-omic biomarkers. Ultimately, treatment decisions should integrate patient preferences, oncologic risk, functional outcomes, and evolving biologic understanding to optimize individualized care for patients with LARC.
引用
- Jethwa KR, Smith JJ, Sanoff H, et al. Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centered. Clin Transl Radiat Oncol. 2026. PMID: 42383070. doi:10.1016/j.ctro.2026.101214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。